Financial Performance of Jasper Therapeutics for the Year Ending December 31 2023
Jasper Therapeutics recorded a net loss of $16.6 million and $64.5 million for the three months and the year ended ...
© 2024 Stocks Today
Tag: JSPR
Jasper Therapeutics Presents Groundbreaking Preclinical Data on Briquilimabs Effectiveness in Preventing Allergic Reactions in Mice
Jasper Therapeutics has announced that they will be presenting groundbreaking preclinical data on the effectiveness of Briquilimab, an anti-CD117 antibody, ...
Popular News
-
Exploring the Rise of AI in Empowering Business and Personal Growth: Trends and Innovations
-
Unlocking the Future: The Rise of Open-Source FPGA Development Tools
-
The Future of Secure Communications: How Quantum-Resistant Encryption is Revolutionizing Wireless Technology
-
The Booming Market of Plant-Based Pharmaceuticals for Neurological Conditions
-
Unlocking Potential: How Recent Acquisitions in the Battery Technology Sector Are Reshaping the Energy Landscape